Clinical trialNCT06834373RecruitingPhase 2Interventional

Golcadomide and Rituximab as Bridging Therapy for Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphoma Before CAR T-cell Therapy

SponsorMayo ClinicEnrollment41Large B-Cell Lymphoma With IRF4 RearrangementRecurrent ALK-Positive Large B-Cell LymphomaRecurrent Aggressive B-Cell Non-Hodgkin LymphomaRecurrent Diffuse Large B-Cell Lymphoma Activated B-Cell TypeRecurrent Diffuse Large B-Cell Lymphoma Associated With Chronic InflammationRecurrent Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type+25 more conditions

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Claire Tiger, MD, PhD
Mayo Clinic
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Mayo Clinic in Arizona
Scottsdale, Arizona, United States
Javier L. Munoz, MD, MBA
Recruiting
Mayo Clinic in Florida
Jacksonville, Florida, United States
Muhamad Alhaj Moustafa, MD, MS
Recruiting
Mayo Clinic Health System in Albert Lea
Albert Lea, Minnesota, United States
Mina Hanna, MD
Recruiting
Mayo Clinic Health Systems-Mankato
Mankato, Minnesota, United States
Amrit B. Singh, MBBS
Recruiting
Mayo Clinic in Rochester
Rochester, Minnesota, United States
Claire Tiger, MD, PhD
Recruiting
Mayo Clinic Health System-Eau Claire Clinic
Eau Claire, Wisconsin, United States
Eyad S. Al-Hattab, MD
Recruiting
Mayo Clinic Health System-Franciscan Healthcare
La Crosse, Wisconsin, United States
Scott H. Okuno, MD
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 2 Apr 2025
Primary completion: 3 Mar 2027
Completion: 3 Mar 2027
Last update posted: 28 Jan 2026
Registered enrollment: 41
Registry id: NCT06834373

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.